Genentech, Inc. has made two vice president appointments: Michael P. Miller to vice president, sales and marketing, HER Family; and David Schenkein, M.D., to vice president, clinical hematology/oncology. Mr. Miller is replacing John Orwin who was promoted to vice president, BioOncology. Mr. Miller will be responsible for leading all sales and marketing activities for Herceptin and Tarceva and will report to Mr. Orwin. He joins the company from Connetics Corp., where he was senior ...